Skip to main content
. 2020 Jun 21;178:114114. doi: 10.1016/j.bcp.2020.114114

Table 2.

Mechanisms, cardiovascular adverse effects, advantages and disadvantages of several medications used in SARS-CoV-2 infection.

Medication MOA Effect on SARS-CoV-2 CV toxicity Advantages Disadvantages Ref
Remdesivir RDRP inhibitor Reduces symptoms in SARS-CoV-2 patients, inhibits SARS-CoV-2 infection in vitro Unknown Established safety profile, resistant to nsp14-ExoN Causes viral resistance, and must be injected [17], [77]
Chloroquine/Hydroxychloroquine Raises endosomal pH and anti-inflammation Blocks SARS-CoV-2 from early endosomes to endolysosomes, blocks glycosylation of ACE2 Myocardial toxicity, QT prolongation, altered cardiac conductivity High oral bioavailability, concentrates in lungs concentrates in the liver, spleen and kidney and efficacy has been debated [17], [79], [80]
Nitazoxanide Blocks pyruvate ferredoxin oxidoreductase in anaerobes Inhibits growth of SARS-CoV-2 and cytokine production from PMNs and IL-6 production Unknown parent drug and metabolite are active, can be given orally Expensive, and safety profile is less understood [17]
Lopinavir/Ritonavir Protease inhibitor/CYP450 inhibitor Shortens median hospital stay in SARS-CoV-2 infected patients QT interval prolongation, and high degree atrioventricular block Well studied, oral route Does not reduce SARS-CoV-2 mortality in recent studies [78], [84]
Ribavirin RDRP inhibitor Inhibits in vitro growth of SARS-CoV-2 at high concentrations Unknown Low cost and well-studied worsens in some patients outcomes and efficacy is debated [17], [76]
Convalescent plasma Performs neutralizing immunoglobulin targeting SARS-CoV-2 Lowers viral load and lead to quick improvement of symptoms in critically ill COVID-19 patients Unknown Immunomodulatory effects: potentially mitigate cytokine storm Ineffective in MERS-CoV prophylaxis and must be injected [87]
Corticosteroids Reduces inflammatory mediators combat the damage from cytokine storm, reducing lung injury Immunosuppression, cardiovascular and metabolic disorders Useful in later stages of infection Must be injected, raises mortality and adverse effect risk if used inappropriately [5], [78]
Ammonium chloride Raises endosomal pH Blocks glycosylation of ACE2 receptors and inhibited viral growth in vitro Ammonia toxicity can lead to bradyarrhythmia Cheap, few apparent drug interactions Not well studied and uncommonly used in humans [17]
ACEI/ARB Reduces Ang II effect and prevents vasoconstriction Upregulates ACE2 and prevents overproduction of Ang II, reduces cardiac and lung injury Hypotension Well studied, low side effect profile, cheap not directly target virus and ACE2 upregulation provides virus with more sites to attack [53]
Tocilizumab Inhibits IL-6 receptor combat the damage from cytokine storm Hypertension, and increased serumcholesterol Inhibit IL-6 and mitigate cytokine storm Expensive and does not target SARS-CoV-2 [30]